PSI Careers Lunch & Learn: Is it AI? Can you spot the fake?

PSI Introduction to Industry Training (ITIT) Course - 2026/2027

An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

AIMS SIG - Open-Source Lunch Bites

Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry. This month’s session, “Graphics Basics,” will introduce the fundamentals of producing graphics using the ggplot2 package.

PSI Career Young Virtual Event (Q2 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Book Club: The AI Con – Joint with ASA Book Club

The Guardian described the authors of this book as refreshingly sarcastic! What is sold to us as AI, they announce, is just "a bill of goods": "A few major well-placed players are poised to accumulate significant wealth by extracting value from other people's creative work, personal data, or labour, and replacing quality services with artificial facsimiles."

PSI Book Club: Another Door Opens – Book Club Special Event

This is a Book Club Special Event in response to the changes in our industry and as a supportive move to create community and connection for those navigating redundancy and uncertainty. Read the book in advance of the book club session then join the zoom call to discuss ideas. There will be breakout groups to connect with others, exchange experiences of how the book has helped, and offer support.

PSI Book Club: Change: How organisations achieve hard-to-image results in uncertain and volatile times

Organizations have to adapt to the transforming landscape of our industry to ensure they continue to be successful in the future. Many of us are feeling the impact of organizational change. By reading John P Kotter’s book we can understand about organizational change and learn how to thrive, rather than just survive, through change. Change, by John P Kotter (and his team), is a summary of all that he has learned over his decades of research and leading change. His book describes why many current approaches to change are inadequate and explains why new solutions need to give people a voice and a role in a new, change-embracing organization. Develop your understanding of organisational change and become empowered to be part of your organisation’s change, by reading Change by John P Kotter and joining the Sept-Dec 2025 book club. You will be invited to join facilitated discussions of the concepts and ideas and apply knowledge from the book in-between sessions.

PSI Career Young Virtual Event (Q3 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Career Young Virtual Event (Q4 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Speaker	Biography
Kimberley Hacquoil	Kim is a highly skilled statistical leader who has worked widely in the pharmaceutical industry. As Chief Data Scientific Officer at Exploristics she provides statistical advice and consultation around drug development options and study design using novel methods and software. Kim has previously worked at GSK and has over 17 years in-depth experience across a wide range of therapeutic areas, mainly in early development. She has led numerous projects, implemented company-wide initiatives and championed new approaches to decision making in clinical development including futility and predictive inference, prior elicitation, and assurance. She also has experience in strategic decision-making and analytics at a portfolio level. Kim currently sits on the Board of Directors for PSI leading the Careers team and is eager to support and develop statisticians in advancing non-technical skills to impact and influence.
Paul Terrill	Paul Terrill is a distinguished statistician known for his significant contributions to the field. With a background in advanced statistical methods, he has played a pivotal role in shaping data analysis techniques. Terrill's work spans various domains, including healthcare, finance, and social sciences, where his expertise has been instrumental in deriving meaningful insights from complex datasets. His commitment to precision and innovation has earned him recognition as a leading figure in the world of statistics.
Ursula Becker	Ursula is leading a team of Evidence Leads (statisticians and health economists) at Roche’s headquarters. She is a medical statistician by training and has also an MBA. After her studies she started her career in market research and database marketing before joining the Pharmaceutical Industry more than 15 years ago. She has worked in different areas of pharmaceutical development, both at a global level and also at the German affiliate across a variety of disease areas (e.g., Oncology, Infectious Diseases, Neurosciences). Ursula is passionate about diversity, equity and inclusion. The topic of disability inclusion is particularly close to her heart. She is chairing the Roche internal network on this topic and has launched CareRing, Roche’s internal community for patients and caregivers a few years ago.

Other Careers Events